OEL Fastrac Catalog

Foeniculum vulgare seed extract (CAS RN 92623-75-1) is the extract of the seeds of the fennel, Foeniculum vulgare. Foeniculum vulgare (Foeniculum vulgare Mill. subspecies vulgare), commonly known as fennel, is a flowering plant species belonging to the Apiaceae family. Fennel is an herb with yellow flowers, widely cultivated for its edible fruits or seeds, which are sweet and dry; when fully ripe, the fruit is considered highly valued. The fruit is often dried for later use, and this dried fruit (seeds), referred to as fennel, represents a major commercial commodity. Fennel has been extensively used in traditional medicine for a wide range of ailments. Fennel is used in various traditional systems of medicine such as the Ayurveda, Unani, Siddha, in the Indian, and Iranian traditional systems of alternative and balancing medicine. Its stem, fruit, leaves, seeds, and whole plant itself are medicinally used in different forms in the treatment of a variety of disease conditions such as abdominal pains, as an antiemetic, as an aperitif, for arthritis, cancer, colic in children, conjunctivitis, constipation, as a depurative, for diarrhea, diuresis, as an emmenagogue, for fever, flatulence, gastralgia, gastritis, insomnia, irritable colon, kidney ailments, as a laxative, for leucorrhea, liver pain, mouth ulcer, and stomachache. It is also used traditionally for symptomatic treatment of minor spasm associated with menstrual periods and as an expectorant in cough associated with cold.

Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.

Please note: Due to the complexity and amount of studies regarding this compound—a Natural Health Product—increased cost is charged.

Why do you need this OEL Fastrac monograph?

OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:

• The numerical OEL and control band assignment needed to determine the level of required engineering controls and personal protective equipment
• A listing of all cited references utilized in the derivation of the OEL and ADE
• An expert review and discussion with respect to the critical endpoints of concern, the rationale for the choice of endpoints, and dose that is to be used in the derivation of the ADE (PDE), as required by the EMA's Guideline on setting health-based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities

Benefits of OEL Fastrac monographs

• Fully documented. Over 20 pages in length, with calculations and cited references.
• Save time! Unsurpassed delivery with instant download.
• Save money. Similar documents cost 5-12 times as much.
• Stay current. Automatic notification of revisions.

How to order

To order an OEL/ADE monograph for Fennel Seed Extract, just click the ADD TO CART button.

HBEL

If you're wondering about HBEL, we have something for you.